1 |
Ministry of Food and Drug Safety. Available at: https://nedrug.mfds.go.kr/index
|
2 |
M.H. Murad, NIV. Asi, M. Alsawas, F. Alahdab. "New evidence Pyramid", Evid Based Med. Vol. 21, No. 4, 125-127, 2016. http://dx.doi.org/10.1136/ebmed-2016-110447
DOI
|
3 |
N.Castle, J. Bowen, N. Spencer, Does wearing CBRN-PPE adversely affect the ability for clinicians to accurately, safely, and speedily draw up drugs? Clin Toxicol (Phila). Vol. 48, No. 6, 522-527, 2010. DOI:10.3109/15563650.2010.491483
DOI
|
4 |
R. M. Adapa, V. Mani, L. J. Murray, B. A. Degnan, A. Ercole, B. Cadman et.al, Errors during the preparation of drug infusions: a randomized controlled trial. British Journal of Anesthesia. Vol. 109, No. 5, 729-34, 2012. doi:10.1093/bja/aes257
DOI
|
5 |
A. D. Stevens, C. Hernandez, S. Jones, M. E. Moreira, J. R. Blumen, E. Hopkins et.al. Color-coded prefilled medication syringes decrease time to delivery and dosing errors in simulated prehospital pediatric resuscitations: A randomized crossover trial. Resuscitation. Vol. 96, 85-91, 2015. DOI: 10.1016/j.resusci tation.2015.07.035
DOI
|
6 |
M. E. Moreira, C. Hernandez, A. D. Stevens, S. Jones, M. Sande, J. R. Blumen, Color-Coded Prefilled Medication Syringes Decrease Time to Delivery and Dosing Error in Simulated Emergency Department Pediatric Resuscitations. Ann Emerg Med. Vol. 66, No. 2, 97-106, 2015. DOI: 10.1016/j.annemergmed.2014.12.035
DOI
|
7 |
Korea Disease Control and Prevention Agency. 2020 Korean Guideline for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. 133-148. 2020
|
8 |
D. D. Degnan, T. N. Bullard, M. B. Davis, Risk of Patient Harm Related to Unnecessary Dilution of Ready-to-Administer Prefilled Syringes: A Literature Review. J Infus Nurs, Vol. 43, No. 3, 146-154, 2020. DOI: 10.1097/nan.0000000000000366
DOI
|
9 |
A. R. Kafal, D. C. Vinh, M. J. Langelier, Prefilled syringes for immunoglobulin G (IgG) replacement therapy: clinical experience from other disease settings, Expert Opin Drug Deliv, Vol. 15, No. 12, 1199-1209, 2018. DOI: 10.1080/17425247.2018.1546692
DOI
|
10 |
Z. Mohanna, S. Kusljic, R. Jarden, Investigation of interventions to reduce nurses' medication errors in adult intensive care units: A systematic review. Aust Crit Care, Vol. 35, No. 4, 466-479, 2021. DOI: 10.1016/j.aucc.2021.05.012
DOI
|
11 |
Expert Rev. Vaccine presentation in the USA: economics of prefilled syringes versus multidose vials for influenza vaccination. Vaccines, Vol. 9, No. 11, 1343-1349, 2021.
DOI
|
12 |
S. Petrou, N. Stallard, S. Gates, R. Lall, For the PARAMEDIC2 Collaborators. A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest. N Engl J Med. Vol. 379, No. 8, 711-21, 2018.
DOI
|
13 |
P. J. Kudenchuk, S. P. Brown, M. Daya, T. Rea, G. Nichol, L. J. Morrison, et al. Amiodarone, lidocaine, or placebo in out-of-hospital cardiac arrest. N Engl J Med. Vol. 375, 1711-22, 2016.
|
14 |
H. h, OH, K. C. Cha, J. H. Lee, D. H. Kim, B. K. Lee, J. S. Park. et al. 2020 Korean Guidelines for Cardiopulmonary Resuscitation. Part 4. Adult advanced life support. Clin Exp Emerg Med. Vol. 8, No. S, 26-40, 2021.
|
15 |
P. J. Kudenchuk, M. Daya, P. Dorian. Resuscitation outcomes consortium I. Amiodarone, lidocaine, or placebo in out-of-hospital cardiac arrest. N Engl J Med. Vol. 375, 802-3, 2016.
|
16 |
P. J. Kudenchuk, L. A. Cobb, M. K. Copass, R. O. Cummins, A. M. Doherty, C. E. Fahrenbruch, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med. Vol. 341, 871-8, 1999.
DOI
|
17 |
I. G. Jacobs, J, C. Finn, G. A. Jelinek, H. F. Oxer, P. L. Thompson. Effect of adrenaline on survival in out-of-hospital cardiac arrest: A randomised double-blind placebo-controlled trial. Resuscitation. Vol. 82, No. 9, 1138-43, 2011
DOI
|
18 |
Korean Council of Professors for Emergency Medical Service. Management of Emergency Patient 5th edition. Seoul: Daehakseorim, 338-355.
|